Hepatitis A: Clinical Trials

21 trials for Hepatitis A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 unknown, 1 active not recruiting, 1 terminated. 21 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 16, Unknown 3, Active not recruiting 1, Terminated 1
Phase 21Unknown 1

Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
Inactivated hepatitis A vaccine (I-HAV) - Hepatitis A, Hepatitis A Virus
Phase 3Active not recruitingChiang Mai University362025-05-252026-05-22
Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents
Mevac-A vaccine, Havrix 720 Junior - HAV, Hepatitis A
Phase 3CompletedChiang Mai University1202024-04-272025-05-04
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL - Hepatitis A, Hep A
Phase 3UnknownBoryung Biopharma Co., Ltd.1062022-12-012022-11-14
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
MenACWY-CRM, Combined inactivated hepatitis A & recombinant hepatitis B, Recombinant hepatitis B vaccine - Meningococcal Disease, Meningococcal Meningitis
Phase 3CompletedNovartis Vaccines2522011-10-012017-06-08
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Varicella Vaccine, Hepatitis A Vaccine - Varicella, Hepatitis A
Phase 2 / Phase 3UnknownUniversity of Sao Paulo General Hospital6002009-06-012009-06-23
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines
Japanese encephalitis vaccine, Japanese encephalitis vaccine (Acambis), Hepatitis A vaccine - Japanese Encephalitis, Hepatitis A
Phase 3CompletedSanofi Pasteur, a Sanofi Company12002008-08-012015-04-21
Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose
Hepatitis A vaccine AVAXIM 80U, Hepatitis A vaccine (HAVRIX 720) - Hepatitis A
Phase 3CompletedSanofi Pasteur, a Sanofi Company7202007-06-012014-01-22
Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Epaxal, Havrix 720 - Hepatitis A
Phase 3CompletedCrucell Holland BV3272007-03-142019-04-08
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Twinrix, interleukin-2 - HIV Infections, Hepatitis A
Phase 3UnknownAalborg University Hospital802007-03-012007-11-01
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Twinrix™ adult - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline512004-11-012018-02-15
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Twinrix™ - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline502004-11-012018-08-17
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
Twinrix™ Adult, Twinrix™ Junior - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline2442004-05-012017-04-20
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
TWINRIX™ ADULT, Engerix TM - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline1782004-02-162018-08-20
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Havrix™, Infanrix™, ActHIB™ - Hepatitis A
Phase 3CompletedGlaxoSmithKline4682003-11-112018-08-20
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
Twinrix™ Adult, Twinrix™ Junior - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline2762003-11-012018-08-20
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
Havrix®, M-M-R®II, VARIVAX® - Hepatitis A
Phase 3CompletedGlaxoSmithKline14742003-10-062018-07-31
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix), Prevnar™ - Hepatitis A
Phase 3CompletedGlaxoSmithKline5212003-09-112018-08-06
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
Combined Hepatitis A and B vaccine - Hepatitis B, Hepatitis A
Phase 3CompletedGlaxoSmithKline1432003-09-012016-09-07
Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients
group1, group2 - HIV Infection
Phase 3CompletedAssistance Publique - Hôpitaux de Paris992003-06-012011-12-16
Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix - Hepatitis A
Phase 3CompletedGlaxoSmithKline10342002-05-012016-09-09

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Hepatitis B (8)  ·  Hepatitis (3)  ·  HIV Infections (2)  ·  Vaccine-Preventable Diseases (2)  ·  Chickenpox (1)  ·  Encephalitis, Japanese (1)  ·  Meningitis, Meningococcal (1)  ·  Meningococcal Infections (1)  ·  Typhoid Fever (1)

Broader conditions

Digestive System Diseases (21)  ·  Enterovirus Infections (21)  ·  Hepatitis, Viral, Human (21)  ·  Infections (21)  ·  Liver Diseases (21)  ·  Picornaviridae Infections (21)  ·  RNA Virus Infections (21)  ·  Virus Diseases (21)  ·  Hepatitis (18)  ·  Blood-Borne Infections (9)  ·  Communicable Diseases (9)  ·  DNA Virus Infections (9)  ·  Hepadnaviridae Infections (8)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)

Interventions

Hepatitis A Vaccines (6)  ·  Chickenpox Vaccine (2)  ·  twinrix (2)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (1)  ·  Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)  ·  Hepatitis B Vaccines (1)  ·  Heptavalent Pneumococcal Conjugate Vaccine (1)  ·  Interleukin-2 (1)  ·  Japanese Encephalitis Vaccines (1)  ·  MenACWY-CRM vaccine (1)  ·  epaxal berna (1)

Sponsors

GlaxoSmithKline (11)  ·  Chiang Mai University (2)  ·  Sanofi Pasteur, a Sanofi Company (2)  ·  Aalborg University Hospital (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Boryung Biopharma Co., Ltd. (1)  ·  Crucell Holland BV (1)  ·  Novartis Vaccines (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Belgium (5)  ·  Thailand (4)  ·  United States (3)  ·  Australia (2)  ·  Czechia (2)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Philippines (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Natchaya Kunanitthaworn, MD (2)  ·  Tavitiya Sudjaritruk, MD, PhD (2)  ·  Glacus S Brito, MD (1)  ·  Henrik Nielsen, MD, DMSci (1)  ·  Odile Launay, MD (1)  ·  Ron Dagan, MD (1)  ·  Shai Ashkenazi, MD (1)

Results publications

PMID 22777096, PMID 24656175, PMID 25483566, PMID 26770041, PMID 27093164